Listed

AbCellera Biologics Inc.

ABCLNasdaqCIK 1703057HealthcareFiscal year ends Dec 31

Reports and events: 102 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AbCellera Biologics Inc., Reports and events
FiledFormWhat it isAccession number
2023-10-1320:03 ET8-K8.01 Other events0001703057-23-000034
2023-08-0316:33 ET10-QQuarterly reportPeriod 2023-06-300001703057-23-000022
2023-08-0316:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001703057-23-000020
2023-06-2016:56 ET8-K5.07 Shareholder vote results0001703057-23-000014
2023-05-2414:36 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001703057-23-000011
2023-05-0416:57 ET10-QQuarterly reportPeriod 2023-03-310001703057-23-000008
2023-05-0416:39 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001703057-23-000005
2023-04-2816:52 ETDEF 14AProxy statement0001140361-23-021664
2023-04-2416:53 ETSC 13D/AOwnership report, active investor, amended0001104659-23-049066
2023-03-1318:14 ET8-K7.01 Regulation FD disclosure0001564590-23-003427
2023-02-2117:04 ET10-KAnnual reportPeriod 2022-12-310001564590-23-002128
2023-02-2116:51 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-23-002126
2022-11-0816:47 ET10-QQuarterly reportPeriod 2022-09-300001564590-22-037060
2022-11-0816:31 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-037057
2022-08-0916:42 ET10-QQuarterly reportPeriod 2022-06-300001564590-22-028784
2022-08-0916:26 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-028771
2022-07-2216:53 ET10-K/AAnnual report, amendedPeriod 2021-12-310001564590-22-026266
2022-07-1917:42 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001564590-22-025922
2022-07-0616:57 ET8-K5.02 Departure or appointment of officers or directors0001564590-22-025392
2022-06-3013:28 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-024914
2022-06-2112:28 ET8-K5.07 Shareholder vote results0001564590-22-023707
2022-05-1016:23 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-019294
2022-05-1016:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-019285
2022-04-2814:33 ETDEF 14AProxy statementPeriod 2022-06-150001140361-22-016463
2022-02-2514:09 ET10-KAnnual reportPeriod 2021-12-310001564590-22-007077
2022-02-2417:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-006755
2022-02-1517:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-005256
2021-12-0716:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001564590-21-059570
2021-12-0313:38 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-059298
2021-11-1016:16 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-056205
2021-11-0917:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-055806
2021-11-0416:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-054498
2021-09-2317:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-048621
2021-09-1516:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-048042
2021-08-1316:31 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-044327
2021-08-1217:21 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-044061
2021-07-1316:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-036460
2021-06-2116:33 ET8-K5.07 Shareholder vote results0001564590-21-033639
2021-06-1017:18 ETS-1Registration statement0001193125-21-187930
2021-05-1716:05 ET8-K/A2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-028375
2021-05-1416:05 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-028008
2021-05-1316:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-027597
2021-04-2816:00 ETDEF 14AProxy statementPeriod 2021-06-150001140361-21-014738
2021-04-0107:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-103256
2021-03-3017:08 ET10-KAnnual reportPeriod 2020-12-310001564590-21-016713
2021-03-2916:29 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-016135
2021-03-0209:01 ET8-K8.01 Other events0001193125-21-064713
2020-12-2816:48 ETSC 13DOwnership report, active investor0001068238-20-000249
2020-12-1008:37 ETS-1/ARegistration statement, amended0001193125-20-314458
2020-12-0706:06 ETS-1/ARegistration statement, amended0001193125-20-311091

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 01:06 ET. Listed shows no prices and gives no investment advice.